EP2629801
SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGATES AND INHIBITORS OF THE PI3K-AKT MTOR PATHWAY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.10.2011EP published:
15.5.2019EP application number:
11835158.4
EPO information:
European Patent Register
Max expiry date:
19.10.2031
Title:
SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGATES AND INHIBITORS OF THE PI3K-AKT MTOR PATHWAY
Timeline
Today
20.10.2011EP application
15.5.2019EP Publication
Owner
Name:
Seattle Genetics, Inc.Address:
21823 30th Drive, S.E., 98021, Bothell, WA, US
Inventor
Name:
LEWIS, Timothy S.Address:
Bothell, Washington, US
Name:
LAW, Che-LeungAddress:
Bothell, Washington, US
Name:
MCEARCHERN, Julie A.Address:
Bothell, Washington, US
Priority
Number:
201161445785 PDate:
23.2.2011Country:
US
Number:
405767 PDate:
22.10.2010Country:
US
Classification
Categories:
A61K 47/68, A61K 45/06, A61K 31/46, A61K 31/4375, A61P 35/00